<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>胰腺癌见解：pORG 分类如何预测生存并指导治疗</title><description>研究人员确定了影响转移性胰腺导管腺癌患者预后的独特分子和免疫特征。</description><link/> https://www.news-medical.net/news/20250115/Pancreatic-cancer-insights-How-pORG-classifications-predict-survival-and-guide-treatment.aspx<comments> https://www.news-medical.net/news/20250115/Pancreatic-cancer-insights-How-pORG-classifications-predict-survival-and-guide-treatment.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=b7196e64-b383-48fe-a846-fd25b94c6f89</guid><pubDate> Wed, 15 Jan 2025 07:58:00 -0500</pubDate> <media:content expression="full" height="1092" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_799949_17369009427854802.jpg" width="2000"><media:description><![CDATA[Pancreatic cancer insights: How pORG classifications predict survival and guide treatment]]></media:description></media:content></item><item><title>新型材料有望治疗多发性骨髓瘤骨病变</title><description>该团队解决了治疗多发性骨髓瘤（一种血癌）的关键挑战，恶性浆细胞在骨髓中积聚，导致 80% 的患者出现衰弱性骨病变。</description><link/> https://www.news-medical.net/news/20250115/Novel-materials-show-promise-in-treating-multiple-myeloma-bone-lesions.aspx<comments> https://www.news-medical.net/news/20250115/Novel-materials-show-promise-in-treating-multiple-myeloma-bone-lesions.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=23c969b6-b402-4f71-ab9c-0bc77cce719d</guid><pubDate> Wed, 15 Jan 2025 07:45:15 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/Osteoporosis_stage_3_of_4_-_upper_limb_bones_-_3d_rendering_-_Crevis_M1_62ee9a3e223b497ca6798e45d894de93-620x480.jpg" width="620"><media:description><![CDATA[Novel materials show promise in treating multiple myeloma bone lesions]]></media:description></media:content></item><item><title> Aurox 将业务拓展至北美</title><description>Aurox 将业务拓展至北美</description><link/>https://www.news-medical.net/news/20250115/Aurox-expands-activity-into-North-America.aspx<comments> https://www.news-medical.net/news/20250115/Aurox-expands-activity-into-North-America.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=3445cda2-44e3-4d05-82e0-fe1135308fcf</guid><pubDate> Wed, 15 Jan 2025 07:39:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/detail_of_microscope_lenses_observing_a_slide_with_sample_wells_in_the_laboratory-angellodeco_e84c7a54b30247a0a1ad679809f0b548-620x480.jpg" width="620"><media:description><![CDATA[Aurox expands activity into North America]]></media:description></media:content></item><item><title> Spear Bio 的新型 pTau 217 血液测试获得 FDA 突破性设备指定，为早期阿尔茨海默病诊断提供可扩展的解决方案</title><description>Spear Bio Inc. 是一家开创下一代超灵敏免疫分析技术的生物技术公司，今天宣布其 pTau 217 血液检测已获得美国食品和药物管理局 (FDA) 的突破性设备称号。</description><link/> https://www.news-medical.net/news/20250115/Spear-Bio-secures-FDA-breakthrough-device-designation-for-its-novel-pTau-217-blood-test-advancing-scalable-solutions-早期阿尔茨海默病诊断.aspx<comments> https://www.news-medical.net/news/20250115/Spear-Bio-secures-FDA-breakthrough-device-designation-for-its-novel-pTau-217-blood-test-advancing-scalable-solutions-早期阿尔茨海默病诊断.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=fc805735-dc26-4e30-a2db-3ac6b6f41d6d</guid><pubDate> Wed, 15 Jan 2025 07:36:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/2/Alzheimers_amyloid_plaque_-_Juan_Gaertner_9638f1223d534b518a192c8478871d65-620x480.jpg" width="620"><media:description><![CDATA[Spear Bio secures FDA breakthrough device designation for its novel pTau 217 blood test, advancing scalable solutions for early Alzheimer's disease diagnosis]]></media:description></media:content></item><item><title> CN Bio与Primetech Corporation签署战略合作伙伴关系，建立OOC解决方案在日本的分销渠道</title><description>CN Bio 是加速药物发现和开发工作流程的片上器官 (OOC) 系统和解决方案的领先供应商，今天宣布已与日本生命科学研究设备分销商 Primetech 建立战略合作伙伴关系。</description><link/> https://www.news-medical.net/news/20250115/CN-Bio-signs-strategic-partnership-with-Primetech-Corporation-to-built-distribution-channel-for-OOC-solutions-in-Japan。 ASPX<comments> https://www.news-medical.net/news/20250115/CN-Bio-signs-strategic-partnership-with-Primetech-Corporation-to-built-distribution-channel-for-OOC-solutions-in-Japan。 aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0f0c23dc-0feb-450d-8907-7b7446b10c59</guid><pubDate> Wed, 15 Jan 2025 07:25:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/Drug_use_and_prohibited_substances._-_Image_-_Monika_Gruszewicz_A1_b3acfd6d2daf44ecbd36979af20eb378-620x480.jpg" width="620"><media:description><![CDATA[CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan]]></media:description></media:content></item><item><title>与 SARS-CoV-2 感染易感性增加相关的遗传风险因素</title><description>研究人员发现了 SARS-CoV-2 感染的一种新的遗传风险因素，为了解该病毒侵入人类细胞的能力提供了新的见解。 SARS-CoV-2 是传播 COVID-19 的病毒。</description><link/> https://www.news-medical.net/news/20250115/Genetic-risk-factor-linked-to-increased-susceptibility-to-SARS-CoV-2-infection.aspx<comments> https://www.news-medical.net/news/20250115/Genetic-risk-factor-linked-to-increased-susceptibility-to-SARS-CoV-2-infection.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=715e71fd-944b-48bd-8c29-ba03f5e9a337</guid><pubDate> Wed, 15 Jan 2025 07:20:36 -0500</pubDate> <media:content expression="full" height="480" type="image/png" url="https://d2jx2rerrg6sh3.cloudfront.net/images/tags/TagImage-5811-45296012395219915055-620x480.png" width="620"><media:description><![CDATA[Genetic risk factor linked to increased susceptibility to SARS-CoV-2 infection]]></media:description></media:content></item><item><title> Pheno Therapeutics 获得领先的多发性硬化症治疗候选药物 PTD802 的临床试验授权</title><description>Pheno Therapeutics Limited 是一家专注于发现和开发用于治疗神经系统疾病的小分子疗法的生物技术公司，今天宣布其已获得英国 MHRA（药品和保健品监管机构）的临床试验授权 (CTA)。主要候选人，PTD802。</description><link/> https://www.news-medical.net/news/20250115/Pheno-Therapeutics-granted-clinical-trial-authorization-for-lead-multiple-sclerosis-therapeutic-candidate-PTD802.aspx<comments> https://www.news-medical.net/news/20250115/Pheno-Therapeutics-granted-clinical-trial-authorization-for-lead-multiple-sclerosis-therapeutic-candidate-PTD802.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=974090fb-6298-4059-9f43-5fa2889544aa</guid><pubDate> Wed, 15 Jan 2025 07:18:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Girl_in_wheelchair-620x480.jpg" width="620"><media:description><![CDATA[Pheno Therapeutics granted clinical trial authorization for lead multiple sclerosis therapeutic candidate PTD802]]></media:description></media:content></item><item><title> Enhanc3D Genomics 推出 3D 多组学解决方案套件以加速药物开发</title><description>3D 基因组学技术的创新者 Enhanc3D Genomics（“Enhanced”）今天宣布推出一套集成的多组学解决方案，以加速和提高药物发现的精确度。</description><link/> https://www.news-medical.net/news/20250115/Enhanc3D-Genomics-launches-suite-of-3D-multi-omics-solutions-to-accelerate-drug-development.aspx<comments> https://www.news-medical.net/news/20250115/Enhanc3D-Genomics-launches-suite-of-3D-multi-omics-solutions-to-accelerate-drug-development.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=d3485b64-588c-477f-8b7b-a969d424d7c2</guid><pubDate> Wed, 15 Jan 2025 07:11:00 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Genomics-620x480.jpg" width="620"><media:description><![CDATA[Enhanc3D Genomics launches suite of 3D multi-omics solutions to accelerate drug development]]></media:description></media:content></item><item><title> IVF 和 ICSI 妊娠显示出更高的致畸药物暴露率</title><description>澳大利亚的一项新研究揭示了与自然受孕相比，通过辅助生殖技术（ART）实现的一些怀孕可能导致出生缺陷的潜在原因。</description><link/> https://www.news-medical.net/news/20250115/IVF-and-ICSI-pregnancies-show-higher-exposure-to-teratogenic-medicines.aspx<comments> https://www.news-medical.net/news/20250115/IVF-and-ICSI-pregnancies-show-higher-exposure-to-teratogenic-medicines.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=430c2a93-40ae-4474-b0c0-4a3cecee89e1</guid><pubDate> Wed, 15 Jan 2025 07:10:19 -0500</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2017/1/In_vitro_Fertilisation-Juan_Gaertner_6bafe07c163e480486030d8125a2dbaf-620x480.jpg" width="620"><media:description><![CDATA[IVF and ICSI pregnancies show higher exposure to teratogenic medicines]]></media:description></media:content></item><item><title> GroceryDB 帮助购物者发现超加工食品</title><description>这个开源数据库利用机器学习来评估食品加工，促进营养安全并让消费者在杂货市场做出明智的选择。</description><link/> https://www.news-medical.net/news/20250115/GroceryDB-helps-shoppers-spot-ultra-processed-foods.aspx<comments> https://www.news-medical.net/news/20250115/GroceryDB-helps-shoppers-spot-ultra-processed-foods.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=98286f14-ed38-42f9-bd41-0d652eab3bd4</guid><pubDate> Wed, 15 Jan 2025 07:04:00 -0500</pubDate> <media:content expression="full" height="1333" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_799987_1736941503943978.jpg" width="2000"><media:description><![CDATA[GroceryDB helps shoppers spot ultra-processed foods]]></media:description></media:content></item></channel></rss>